{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:38:14Z","timestamp":1791218294673,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>This study aimed to evaluate in detail the short- and long-term humoral responses to the BNT162b2 (BioNTech, SE, Mainz, Germany\/Pfizer Inc, New York, NY) vaccine in immunosuppressed children 5\u201311 years old compared with healthy children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A prospective cohort study was conducted with immunosuppressed and healthy children 5\u201311 years of age following complete vaccination, defined as 3 doses of the BNT162b2 vaccine for immunosuppressed participants and 2 doses for healthy participants. The primary endpoints included IgG antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and receptor-binding domain, as well as neutralizing capacity, 1- and 6-months postvaccination. Secondary endpoints included evaluations of breakthrough infections and cellular immune responses against SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Thirty-five participants (20 healthy and 15 immunosuppressed) were included in the study. We could not demonstrate a different serological response in healthy children compared with immunosuppressed children in levels of anti-Spike IgG, anti-receptor-binding domain IgG, or neutralizing antibody at 1- and 6-months postvaccination. Humoral responses declined significantly by 6 months in healthy children; we could not demonstrate a significant decline in immunosuppressed children. Cellular immunity at 6 months showed a strong correlation with humoral response (\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      \u2265 0.74). Overall, the immunological response appeared protective for up to 6 months in both healthy and immunosuppressed participants, with only 1 breakthrough infection in a healthy child.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>After 3 vaccine doses, immunosuppressed children demonstrate 6-month immune comparable to healthy children who received 2 doses. Despite a decline in humoral responses over time, there were no infections, supporting the effectiveness of current coronavirus disease 2019 vaccination strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005042","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T05:00:17Z","timestamp":1764910817000},"page":"258-263","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Short- and Long-term Humoral Response of Immunosuppressed Children to SARS-CoV-2 BNT162b2 Vaccine"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-3455","authenticated-orcid":false,"given":"Alfredo","family":"Tagarro","sequence":"first","affiliation":[{"name":"Innovaci\u00f3n e investigaci\u00f3n en Pediatr\u00eda Global, Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"},{"name":"Department of Pediatrics, Infanta Sof\u00eda University Hospital, Fundaci\u00f3n para la Investigaci\u00f3n Biom\u00e9dica e Innovaci\u00f3n Hospital Universitario Infanta Sof\u00eda y Hospital del Henares (FIIB HUIS HHEN), Madrid, Spain"},{"name":"Faculty of Medicine, Universidad Europea de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8566-8430","authenticated-orcid":false,"given":"Irati","family":"Gastesi","sequence":"additional","affiliation":[{"name":"Innovaci\u00f3n e investigaci\u00f3n en Pediatr\u00eda Global, Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3356-4032","authenticated-orcid":false,"given":"An","family":"Hotterbeekx","sequence":"additional","affiliation":[{"name":"Molecular Pathology Group, Cell Biology and Histology, Global Health Institute, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-2386","authenticated-orcid":false,"given":"David","family":"Aguilera-Alonso","sequence":"additional","affiliation":[{"name":"Innovaci\u00f3n e investigaci\u00f3n en Pediatr\u00eda Global, Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"},{"name":"Pediatric Infectious Diseases Unit, Hospital Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-8026","authenticated-orcid":false,"given":"Angelina","family":"Konnova","sequence":"additional","affiliation":[{"name":"Molecular Pathology Group, Cell Biology and Histology, Global Health Institute, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshita","family":"Gupta","sequence":"additional","affiliation":[{"name":"Molecular Pathology Group, Cell Biology and Histology, Global Health Institute, Antwerp, Belgium"},{"name":"Laboratorio UR Salud, Hospital Universitario Infanta Sof\u00eda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Salso","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-7896","authenticated-orcid":false,"given":"Matilda","family":"Berkell","sequence":"additional","affiliation":[{"name":"Molecular Pathology Group, Cell Biology and Histology, Global Health Institute, Antwerp, Belgium"},{"name":"Laboratorio UR Salud, Hospital Universitario Infanta Sof\u00eda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Plata","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3747-9265","authenticated-orcid":false,"given":"Sara","family":"Dom\u00ednguez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Innovaci\u00f3n e investigaci\u00f3n en Pediatr\u00eda Global, Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4403-1023","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Ballesteros","sequence":"additional","affiliation":[{"name":"Innovaci\u00f3n e investigaci\u00f3n en Pediatr\u00eda Global, Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4230-5035","authenticated-orcid":false,"given":"\u00c1ngela","family":"Manzanares","sequence":"additional","affiliation":[{"name":"Innovaci\u00f3n e investigaci\u00f3n en Pediatr\u00eda Global, Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Oltra","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Innovaci\u00f3n e investigaci\u00f3n en Pediatr\u00eda Global, Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Pinto","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universidad Europea de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Guill\u00e9n","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9365-0413","authenticated-orcid":false,"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[{"name":"Penta Foundation, Padova, Italy"},{"name":"Division of Pediatric Infectious Diseases, Department for Women\u2019s and Children\u2019s Health, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-903X","authenticated-orcid":false,"given":"Cinta","family":"Moraleda","sequence":"additional","affiliation":[{"name":"Innovaci\u00f3n e investigaci\u00f3n en Pediatr\u00eda Global, Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"},{"name":"Pediatric Infectious Diseases Unit, 12 de Octubre University Hospital, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9466-6732","authenticated-orcid":false,"given":"Samir","family":"Kumar-Singh","sequence":"additional","affiliation":[{"name":"Molecular Pathology Group, Cell Biology and Histology, Global Health Institute, Antwerp, Belgium"},{"name":"Laboratorio UR Salud, Hospital Universitario Infanta Sof\u00eda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"R1-20260615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","article-title":"Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient.","volume":"223","author":"Baang","year":"2021","journal-title":"J Infect Dis"},{"key":"R2-20260615","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jinf.2021.12.035","article-title":"Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis.","volume":"84","author":"Marra","year":"2022","journal-title":"J Infect"},{"key":"R5-20260615","doi-asserted-by":"crossref","first-page":"1502598","DOI":"10.3389\/fimmu.2024.1502598","article-title":"Reduced durability of hybrid immunity to SARS-CoV-2 in immunocompromised children.","volume":"15","author":"Zhong","year":"2024","journal-title":"Front Immunol"},{"key":"R6-20260615","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R7-20260615","doi-asserted-by":"crossref","first-page":"e29820","DOI":"10.1002\/jmv.29820","article-title":"Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV.","volume":"96","author":"Gupta","year":"2024","journal-title":"J Med Virol"},{"key":"R8-20260615","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00467-021-05256-9","article-title":"Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients.","volume":"37","author":"Crane","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"R9-20260615","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41390-022-02374-4","article-title":"Humoral and cellular response to the COVID-19 vaccine in immunocompromised children.","volume":"94","author":"Morgans","year":"2023","journal-title":"Pediatr Res"},{"key":"R10-20260615","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00467-022-05679-y","article-title":"Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients.","volume":"38","author":"Kermond","year":"2023","journal-title":"Pediatr Nephro"},{"key":"R11-20260615","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/ibd\/izab194","article-title":"Seroconversion following SARS-CoV-2 infection or vaccination in pediatric IBD patients.","volume":"27","author":"Spencer","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"R12-20260615","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/ibd\/izab207","article-title":"Antibody responses to SARS-CoV-2 after infection or vaccination in children and young adults with inflammatory bowel disease.","volume":"28","author":"Dailey","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"R13-20260615","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12969-022-00724-4","article-title":"Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases.","volume":"20","author":"Udaondo","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"R14-20260615","doi-asserted-by":"crossref","first-page":"SI205","DOI":"10.1093\/rheumatology\/keac352","article-title":"Immunogenicity 6 months post COVID-19 mRNA vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.","volume":"62","author":"Dimopoulou","year":"2023","journal-title":"Rheumatology"},{"key":"R15-20260615","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/ibd\/izae225","article-title":"Durable immune response and long-term efficacy of COVID-19 vaccination in children with inflammatory bowel disease.","volume":"31","author":"Kastl","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"R16-20260615","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-024-00866-4","article-title":"COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children.","volume":"9","author":"Roznik","year":"2024","journal-title":"NPJ Vaccines"},{"key":"R17-20260615","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/v15071553","article-title":"Reduced humoral and cellular immune response to primary COVID-19 mRNA vaccination in kidney transplanted children aged 5\u201311 years.","volume":"15","author":"Lalia","year":"2023","journal-title":"Viruses"},{"key":"R18-20260615","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/vaccines11010195","article-title":"COVID-19 mRNA vaccine tolerance and immunogenicity in hematopoietic stem cell transplantation recipients aged 5\u201311 years old\u2013non-randomized clinical trial.","volume":"11","author":"Matkowska-Kocjan","year":"2023","journal-title":"Vaccines"},{"key":"R19-20260615","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2.","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"R20-20260615","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.13091","article-title":"Correlates of protection against SARS-CoV-2 infection and COVID-19 disease.","volume":"310","author":"Goldblatt","year":"2022","journal-title":"Immunol Rev"},{"key":"R21-20260615","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-024-09570-w","article-title":"QuantiFERON SARS-CoV-2 assay for the evaluation of cellular immunity after immunization with mRNA SARS-CoV-2 vaccines: a systematic review and meta-analysis.","volume":"73","author":"Dourdouna","year":"2025","journal-title":"Immunol Res"},{"key":"R22-20260615","doi-asserted-by":"crossref","first-page":"e2022059844","DOI":"10.1542\/peds.2022-059844","article-title":"Failure to complete multidose vaccine series in early childhood.","volume":"152","author":"Michels","year":"2023","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:00:41Z","timestamp":1781553641000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005042","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}